First Citizens Bank & Trust’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.32M | Sell |
73,799
-1,072
| -1% | -$141K | 0.14% | 95 |
|
|
2026
Q1 | $10.4M | Buy |
74,871
+820
| +1% | +$115K | 0.22% | 78 |
|
|
2025
Q4 | $9.09M | Buy |
74,051
+1,580
| +2% | +$192K | 0.19% | 91 |
|
|
2025
Q3 | $8.04M | Buy |
72,471
+61,959
| +589% | +$7.04M | 0.17% | 96 |
|
|
2025
Q2 | $1.17M | Sell |
10,512
-4,116
| -28% | -$438K | 0.02% | 261 |
|
|
2025
Q1 | $1.64M | Sell |
14,628
-840
| -5% | -$86.7K | 0.04% | 197 |
|
|
2024
Q4 | $1.43M | Buy |
15,468
+193
| +1% | +$17.4K | 0.03% | 211 |
|
|
2024
Q3 | $1.28M | Buy |
15,275
+253
| +2% | +$19.3K | 0.03% | 222 |
|
|
2024
Q2 | $1.03M | Buy |
15,022
+46
| +0.3% | +$3.07K | 0.02% | 240 |
|
|
2024
Q1 | $1.1M | Buy |
+14,976
| New | +$1.15M | 0.02% | 237 |
|
|
2023
Q4 | – | Sell |
-5,458
| Closed | -$409K | – | 367 |
|
|
2023
Q3 | $409K | Buy |
5,458
+329
| +6% | +$25.3K | 0.01% | 262 |
|
|
2023
Q2 | $395K | Sell |
5,129
-493
| -9% | -$39.3K | 0.01% | 271 |
|
|
2023
Q1 | $466K | Sell |
5,622
-437
| -7% | -$36.2K | 0.01% | 234 |
|
|
2022
Q4 | $520K | Buy |
6,059
+294
| +5% | +$23.3K | 0.02% | 212 |
|
|
2022
Q3 | $356K | Buy |
5,765
+28
| +0.5% | +$1.77K | 0.01% | 243 |
|
|
2022
Q2 | $355K | Buy |
5,737
+1,935
| +51% | +$120K | 0.01% | 261 |
|
|
2022
Q1 | $226K | Sell |
3,802
-14
| -0.4% | -$895 | 0.01% | 381 |
|
|
2021
Q4 | $277K | Sell |
3,816
-375
| -9% | -$25.8K | 0.01% | 322 |
|
|
2021
Q3 | $293K | Buy |
4,191
+95
| +2% | +$6.67K | 0.01% | 294 |
|
|
2021
Q2 | $282K | Sell |
4,096
-50
| -1% | -$3.34K | 0.01% | 312 |
|
|
2021
Q1 | $268K | Buy |
4,146
+32
| +0.8% | +$2.06K | 0.01% | 326 |
|
|
2020
Q4 | $240K | Sell |
4,114
-16,508
| -80% | -$996K | 0.01% | 324 |
|
|
2020
Q3 | $1.3M | Sell |
20,622
-14,769
| -42% | -$1.02M | 0.09% | 164 |
|
|
2020
Q2 | $2.72M | Buy |
35,391
+10,874
| +44% | +$833K | 0.23% | 97 |
|
|
2020
Q1 | $1.83M | Buy |
24,517
+19,637
| +402% | +$1.36M | 0.22% | 102 |
|
|
2019
Q4 | $317K | Sell |
4,880
-239
| -5% | -$15.6K | 0.03% | 249 |
|
|
2019
Q3 | $325K | Buy |
5,119
+220
| +4% | +$14.4K | 0.04% | 252 |
|
|
2019
Q2 | $331K | Sell |
4,899
-74
| -1% | -$4.87K | 0.04% | 346 |
|
|
2019
Q1 | $323K | Sell |
4,973
-25
| -0.5% | -$1.66K | 0.04% | 348 |
|
|
2018
Q4 | $313K | Sell |
4,998
-164
| -3% | -$11.5K | 0.04% | 277 |
|
|
2018
Q3 | $398K | Sell |
5,162
-101
| -2% | -$7.63K | 0.04% | 260 |
|
|
2018
Q2 | $373K | Buy |
5,263
+38
| +0.7% | +$2.68K | 0.05% | 272 |
|
|
2018
Q1 | $394K | Buy |
5,225
+176
| +3% | +$14K | 0.05% | 248 |
|
|
2017
Q4 | $362K | Sell |
5,049
-86
| -2% | -$6.53K | 0.05% | 252 |
|
|
2017
Q3 | $416K | Sell |
5,135
-6,966
| -58% | -$533K | 0.05% | 244 |
|
|
2017
Q2 | $857K | Sell |
12,101
-4,311
| -26% | -$287K | 0.11% | 179 |
|
|
2017
Q1 | $1.11M | Sell |
16,412
-57,518
| -78% | -$4.04M | 0.14% | 158 |
|
|
2016
Q4 | $5.29M | Sell |
73,930
-31,330
| -30% | -$2.33M | 0.58% | 52 |
|
|
2016
Q3 | $8.33M | Sell |
105,260
-11,351
| -10% | -$922K | 0.76% | 38 |
|
|
2016
Q2 | $9.73M | Sell |
116,611
-24,917
| -18% | -$2.21M | 0.87% | 32 |
|
|
2016
Q1 | $13M | Sell |
141,528
-5,888
| -4% | -$531K | 1.09% | 24 |
|
|
2015
Q4 | $14.9M | Sell |
147,416
-18,300
| -11% | -$1.9M | 1.09% | 23 |
|
|
2015
Q3 | $16.3M | Buy |
165,716
+18,816
| +13% | +$2.09M | 1.21% | 18 |
|
|
2015
Q2 | $17.2M | Buy |
146,900
+51,872
| +55% | +$5.67M | 1.19% | 17 |
|
|
2015
Q1 | $9.32M | Buy |
95,028
+1,395
| +1% | +$142K | 0.64% | 50 |
|
|
2014
Q4 | $8.83M | Buy |
93,633
+61,772
| +194% | +$6.39M | 0.68% | 54 |
|
|
2014
Q3 | $3.39M | Sell |
31,861
-104
| -0.3% | -$10.2K | 0.28% | 101 |
|
|
2014
Q2 | $2.65M | Buy |
31,965
+17,349
| +119% | +$1.35M | 0.23% | 101 |
|
|
2014
Q1 | $1.04M | Buy |
14,616
+11,774
| +414% | +$923K | 0.09% | 145 |
|
|
2013
Q4 | $213K | Sell |
2,842
-141,248
| -98% | -$9.84M | 0.02% | 305 |
|
|
2013
Q3 | $9.06M | Buy |
144,090
+2,553
| +2% | +$153K | 0.35% | 75 |
|
|
2013
Q2 | $7.26M | Buy |
+141,537
| New | +$7.38M | 0.3% | 90 |
|
Other funds holding GILD
LMFP
CIM
CGH
CNB
AP
COPPSERS
First Citizens Bank & Trust's GILD Position: Q2 2026 in Review
First Citizens Bank & Trust reduced its Gilead Sciences (GILD) stake by 1.4% in Q2 2026, selling an estimated $141K and leaving 73,799 shares worth $9.32M. The position accounts for 0.14% of the portfolio, ranked #95.
First Citizens Bank & Trust first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.2M in Q2 2015. 396 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- First Citizens Bank & Trust held 73,799 shares of Gilead Sciences worth $9.32M as of Q2 2026.
- First Citizens Bank & Trust sold 1,072 Gilead Sciences shares in Q2 2026, an estimated $141K.
- Gilead Sciences made up 0.14% of First Citizens Bank & Trust's portfolio in Q2 2026, its #95 holding.
- First Citizens Bank & Trust first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- First Citizens Bank & Trust's Gilead Sciences position peaked at $17.2M in Q2 2015.
- 396 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on First Citizens Bank & Trust's 13F filing for Q2 2026, filed 13 Jul 2026.